Literature DB >> 8083956

Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.

J Dubuisson1, H H Hsu, R C Cheung, H B Greenberg, D G Russell, C M Rice.   

Abstract

Hepatitis C virus (HCV) encodes two putative virion glycoproteins (E1 and E2) which are released from the polyprotein by signal peptidase cleavage. In this report, we have characterized the complexes formed between E1 and E2 (called E1E2) for two different HCV strains (H and BK) and studied their intracellular localization. Vaccinia virus and Sindbis virus vectors were used to express the HCV structural proteins in three different cell lines (HepG2, BHK-21, and PK-15). The kinetics of association between E1 and E2, as studied by pulse-chase analysis and coprecipitation of E2 with an anti-E1 monoclonal antibody, indicated that formation of stable E1E2 complexes is slow. The times required for half-maximal association between E1 and E2 were 60 to 85 min for the H strain and more than 165 min for the BK strain. In the presence of nonionic detergents, two forms of E1E2 complexes were detected. The predominant form was a heterodimer of E1 and E2 stabilized by noncovalent interactions. A minor fraction consisted of heterogeneous disulfide-linked aggregates, which most likely represent misfolded complexes. Posttranslational processing and localization of the HCV glycoproteins were examined by acquisition of endoglycosidase H resistance, subcellular fractionation, immunofluorescence, cell surface immunostaining, and immunoelectron microscopy. HCV glycoproteins containing complex N-linked glycans were not observed, and the proteins were not detected at the cell surface. Rather, the proteins localized predominantly to the endoplasmic reticular network, suggesting that some mechanism exists for their retention in this compartment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083956      PMCID: PMC237034     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation.

Authors:  J M Wahlberg; W A Boere; H Garoff
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

3.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

4.  Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells.

Authors:  D R Fitzpatrick; T Zamb; M D Parker; S van Drunen Littel-van den Hurk; L A Babiuk; M J Lawman
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Molecular cloning and amino acid sequence of peptide-N4-(N-acetyl-beta-D-glucosaminyl)asparagine amidase from flavobacterium meningosepticum.

Authors:  A L Tarentino; G Quinones; A Trumble; L M Changchien; B Duceman; F Maley; T H Plummer
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

7.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

8.  Maturation of measles virus hemagglutinin glycoprotein.

Authors:  T Kohama; T A Sato; F Kobune; A Sugiura
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

9.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas.

Authors:  D G Bole; L M Hendershot; J F Kearney
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

View more
  167 in total

1.  Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing.

Authors:  S M Amberg; C M Rice
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Subcellular localization and topology of the p7 polypeptide of hepatitis C virus.

Authors:  Séverine Carrère-Kremer; Claire Montpellier-Pala; Laurence Cocquerel; Czeslaw Wychowski; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum.

Authors:  Ivo C Lorenz; Steven L Allison; Franz X Heinz; Ari Helenius
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Hepatitis C virus envelope proteins bind lactoferrin.

Authors:  M Yi; S Kaneko; D Y Yu; S Murakami
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Monoclonal antibodies reveal multiple forms of expression of human microsomal epoxide hydrolase.

Authors:  Hongying Duan; Akira Takagi; Hidekazu Kayano; Isamu Koyama; Christophe Morisseau; Bruce D Hammock; Toshitaka Akatsuka
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-28       Impact factor: 4.219

6.  CD81-dependent binding of hepatitis C virus E1E2 heterodimers.

Authors:  Laurence Cocquerel; Chiung-Chi Kuo; Jean Dubuisson; Shoshana Levy
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.

Authors:  Stéphanie B N Serre; Henrik B Krarup; Jens Bukh; Judith M Gottwein
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

8.  Folding of hepatitis C virus E1 glycoprotein in a cell-free system.

Authors:  M Merola; M Brazzoli; F Cocchiarella; J M Heile; A Helenius; A J Weiner; M Houghton; S Abrignani
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.

Authors:  Ania Owsianka; Alexander W Tarr; Vicky S Juttla; Dimitri Lavillette; Birke Bartosch; François-Loïc Cosset; Jonathan K Ball; Arvind H Patel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans.

Authors:  Alex S Powlesland; Tanja Fisch; Maureen E Taylor; David F Smith; Bérangère Tissot; Anne Dell; Stefan Pöhlmann; Kurt Drickamer
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.